Volume Targeted Mask Ventilation Versus Pressure Ventilation in Preterm Infants
VOLT
1 other identifier
interventional
52
1 country
1
Brief Summary
This is a pilot trial to assess the feasibility of volume Targeted Ventilation in the Delivery Room. Preterm infants will be randomized to pressure guided or volume targeted ventilation during respiratory support in the delivery room
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 21, 2021
CompletedFirst Posted
Study publicly available on registry
December 3, 2021
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 17, 2025
CompletedJanuary 13, 2026
January 1, 2026
1.1 years
October 21, 2021
January 12, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Percentage of of eligible participants (=infants requiring PPV) who have the intervention performed correctly without protocol deviation (=cross over to control group when randomized to VTV-group)
Percentage of Participants who have received allocated treatment
Through study completion (total 18 months)
Secondary Outcomes (15)
Number of participants with mortality
up to 6 months of NICU admission
Number of participants with severe brain injury on cranial ultrasound
up to 6 months of NICU admission
Number of participants with severe retinopathy of prematurity (stage 3 or higher)
up to 6 months of NICU admission
Number of participants with bronchopulmonary dysplasia at 36 weeks corrected age
At 36 weeks corrected age
Number of participants with Bronchopulmonary dysplasia at 40 weeks corrected age
At 40 weeks corrected age
- +10 more secondary outcomes
Other Outcomes (2)
Resuscitators subjective workload performing mask ventilation
within the first 10 min after birth
Resuscitators qualitative feedback on using VTV-PPV in the delivery room
within the first 10 min after birth
Study Arms (2)
Volume Targeted Ventilation
EXPERIMENTALPositive pressure ventilation will be provided using a set tidal volume
Pressure guided Ventilation
ACTIVE COMPARATORPositive pressure ventilation will be provided using a set peak inflation pressure
Interventions
Positive pressure ventilation will be provided using a set tidal volume
Positive pressure ventilation will be provided using a set peak inflation pressure
Eligibility Criteria
You may qualify if:
- Born between 23+0/7 to 28+6/7 weeks' gestation
- Considered suitable for full resuscitation, i.e., no parental request or antenatal decision to forego resuscitation
- Informed parental consent
You may not qualify if:
- Major congenital or chromosomal malformation
- Conditions that might have an adverse effect on breathing or ventilation (e.g., high risk for lung hypoplasia, congenital diaphragmatic hernia)
- Congenital heart disease requiring intervention in the neonatal period
- Hydrops requiring intervention in the neonatal period
- Neonatal resuscitation initiated before NICU team arrival
- Infants who are born outside of study center and transported to center after delivery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal Alexandra Hospital
Edmonton, Alberta, T5H 3V9, Canada
Related Publications (1)
Law BHY, Yaskina M, Davis PG, Polglase G, Dunn M, Mukerji A, Schmolzer GM. Study protocol for the volume targeted mask ventilation versus pressure ventilation in preterm infants-the VOLT-trial. Front Pediatr. 2026 Jan 6;13:1743460. doi: 10.3389/fped.2025.1743460. eCollection 2025.
PMID: 41567425DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Georg Schmölzer, MD, PhD
University of Alberta
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 21, 2021
First Posted
December 3, 2021
Study Start
October 1, 2024
Primary Completion
October 30, 2025
Study Completion
December 17, 2025
Last Updated
January 13, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Protocol will be published within 18 months
The protocol will be published in an open access journal and data can be requested from the principal investigator